Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deafness in myxoedema.

W Van't Hoff, D W Stuart

    The Quarterly Journal of Medicine
    |April 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Hearing loss is common in patients with myxedema (thyroid disease). Treatment with thyroxine can improve or restore hearing in many affected individuals, especially those with severe cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The orthopaedic management of lower limb deformity in hypophosphataemic rickets.

    Journal of children's orthopaedics·2017
    Same author

    Surgical treatment of children with hyperparathyroidism: single centre experience.

    Journal of pediatric surgery·2014
    Same author

    Extending the clinical research network approach to all of healthcare.

    Annals of oncology : official journal of the European Society for Medical Oncology·2011
    Same author

    Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases.

    Nephron. Physiology·2010
    Same author

    Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.

    Nephron. Physiology·2009
    Same author

    Life-threatening hypernatraemic dehydration in breastfed babies.

    Archives of disease in childhood·2006
    Same journal

    Megaloblastic anaemia of pregnancy and the puerperium; a review of forty-five cases with special reference to their response to treatment.

    The Quarterly journal of medicine·2014
    Same journal

    Carcinoma of the bronchus; a clinical and pathological survey of 866 cases.

    The Quarterly journal of medicine·2014
    Same journal

    Heart failure in acute nephritis.

    The Quarterly journal of medicine·2014
    Same journal

    Uraemia complicating low salt treatment of heart failure.

    The Quarterly journal of medicine·2014
    Same journal

    The effect of tobacco on lung-volume.

    The Quarterly journal of medicine·2014
    Same journal

    Chronic monocytic leukaemia.

    The Quarterly journal of medicine·2014
    See all related articles

    Area of Science:

    • Endocrinology
    • Otolaryngology

    Background:

    • Myxedema, a condition of hypothyroidism, is associated with various systemic effects.
    • Hearing impairment is a potential, yet often overlooked, complication of myxedema.

    Purpose of the Study:

    • To investigate the prevalence and characteristics of deafness in patients with myxedema.
    • To assess the impact of thyroid hormone replacement therapy on hearing function in these patients.

    Main Methods:

    • A consecutive series of 48 patients with myxedema underwent audiological assessment.
    • Hearing was re-evaluated after treatment with thyroxine to achieve a euthyroid state.

    Main Results:

    • Deafness was present in 85% of the patients studied.

    Related Experiment Videos

  • Severe myxedema correlated with a higher incidence of hearing loss.
  • Following thyroxine treatment, 73% of deaf ears showed hearing improvement, with 23% returning to normal.

    • Conclusions:

    • Deafness is a frequent comorbidity in myxedema.
    • Thyroxine therapy can significantly improve hearing function in patients with myxedema-associated hearing loss.